Efficacy and safety of pregnenolone augmentation in the management of schizophrenia patients: a randomised double-blind placebo-controlled trial
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Prasterone; Pregnenolone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 21 May 2008 Biomarkers information updated
- 29 May 2007 Status changed from recruiting to completed.
- 20 Nov 2005 New trial record.